Orange Book product · Generic (ANDA)
DIMENHYDRINATE
DIMENHYDRINATE
At a glance
Jun 23, 2004
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 23, 2004
22 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
DIMENHYDRINATE
Strength
50MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 040519
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of DIMENHYDRINATE
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 084767 · BAXTER HLTHCARE
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 083531 · WATSON LABS
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 080615 · WATSON LABS TEVA
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 084316 · WYETH AYERST
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 080715 · ALRA
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 080841 · HEATHER
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 085985 · NEXGEN PHARMA INC
- —DIMENHYDRINATEGeneric (ANDA)
ANDA 085166 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
